Clinical Trial Update: Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating arthrocentesis with platelet-rich plasma and a COX-2 inhibitor for temporomandibular disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorders

Drugs mentioned

• Cyclooxygenase-2 inhibitor
• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Suez Canal University | Conditions: Temporomandibular Joint Internal Derangement | Phase 3 | Status: COMPLETED